353 related articles for article (PubMed ID: 15282403)
1. Time course of cII gene mutant manifestation in the liver, spleen, and bone marrow of N-ethyl-N-nitrosourea-treated Big Blue transgenic mice.
Wang J; Liu X; Heflich RH; Chen T
Toxicol Sci; 2004 Nov; 82(1):124-8. PubMed ID: 15282403
[TBL] [Abstract][Full Text] [Related]
2. Comparison of mutant frequencies at the transgenic lambda LacI and cII/cI loci in control and ENU-treated Big Blue mice.
Zimmer DM; Harbach PR; Mattes WB; Aaron CS
Environ Mol Mutagen; 1999; 33(3):249-56. PubMed ID: 10334627
[TBL] [Abstract][Full Text] [Related]
3. Sequencing analysis of mutations induced by N-ethyl-N-nitrosourea at different sampling times in mouse bone marrow.
Wang J; Chen T
J Appl Toxicol; 2010 Mar; 30(2):133-41. PubMed ID: 19764070
[TBL] [Abstract][Full Text] [Related]
4. DNA adducts, mutant frequencies, and mutation spectra in various organs of lambda lacZ mice exposed to ethylating agents.
Mientjes EJ; Luiten-Schuite A; van der Wolf E; Borsboom Y; Bergmans A; Berends F; Lohman PH; Baan RA; van Delft JH
Environ Mol Mutagen; 1998; 31(1):18-31. PubMed ID: 9464312
[TBL] [Abstract][Full Text] [Related]
5. Frequency and spectrum of ethylnitrosourea-induced mutation at the hprt and lacI loci in splenic lymphocytes of exposed lacI transgenic mice.
Walker VE; Gorelick NJ; Andrews JL; Craft TR; deBoer JG; Glickman BW; Skopek TR
Cancer Res; 1996 Oct; 56(20):4654-61. PubMed ID: 8840980
[TBL] [Abstract][Full Text] [Related]
6. A study of ENU-induced mutagenesis in the mouse using the restriction site mutation (RSM) assay.
Jenkins GJ; Takahashi N; Parry JM
Teratog Carcinog Mutagen; 1999; 19(4):281-92. PubMed ID: 10406892
[TBL] [Abstract][Full Text] [Related]
7. Organ variation in the mutagenicity of ethylnitrosourea in Muta mouse: results of the collaborative study on the transgenic mutation assay by JEMS/MMS. The Collaborative Study Group for the Transgenic Mouse Mutation Assay Mammalian Mutagenesis Study Group of the Environmental Mutagen Society of Japan.
Environ Mol Mutagen; 1996; 28(4):363-75. PubMed ID: 8991065
[TBL] [Abstract][Full Text] [Related]
8. Temporal and molecular characteristics of lacZ mutations in somatic tissues of transgenic mice.
Douglas GR; Jiao J; Gingerich JD; Soper LM; Gossen JA
Environ Mol Mutagen; 1996; 28(4):317-24. PubMed ID: 8991059
[TBL] [Abstract][Full Text] [Related]
9. Age-dependent sensitivity of Big Blue transgenic mice to the mutagenicity of N-ethyl-N-nitrosourea (ENU) in liver.
Mei N; Heflich RH; Moore MM; Chen T
Mutat Res; 2005 May; 572(1-2):14-26. PubMed ID: 15790487
[TBL] [Abstract][Full Text] [Related]
10. Partial hepatectomy strongly increased the mutagenicity of N-ethyl-N-nitrosourea in MutaMouse liver.
Hara T; Sui H; Kawakami K; Shimada Y; Shibuya T
Environ Mol Mutagen; 1999; 34(2-3):121-3. PubMed ID: 10529735
[TBL] [Abstract][Full Text] [Related]
11. Mutational response at the splenic T-lymphocyte hprt locus in mice treated as neonates: contrasting effects of the carcinogens N-ethyl-N-nitrosourea, dimethylnitrosamine, and 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine.
Dass SB; Heflich RH; Casciano DA
Environ Mol Mutagen; 1998; 31(3):243-7. PubMed ID: 9585262
[TBL] [Abstract][Full Text] [Related]
12. N-ethyl-N-nitrosourea (ENU) increased brain mutations in prenatal and neonatal mice but not in the adults.
Slikker W; Mei N; Chen T
Toxicol Sci; 2004 Sep; 81(1):112-20. PubMed ID: 15159527
[TBL] [Abstract][Full Text] [Related]
13. Relationships between exposure, cell loss and proliferation, and manifestation of Hprt mutant T cells following treatment of preweanling, weanling, and adult male mice with N-ethyl-N-nitrosourea.
Walker VE; Jones IM; Crippen TL; Meng Q; Walker DM; Bauer MJ; Reilly AA; Tates AD; Nakamura J; Upton PB; Skopek TR
Mutat Res; 1999 Dec; 431(2):371-88. PubMed ID: 10636002
[TBL] [Abstract][Full Text] [Related]
14. Unexpected genetic toxicity to rodents of the N',N'-dimethyl analogues of MNU and ENU.
Tinwell H; Paton D; Guttenplan JB; Ashby J
Environ Mol Mutagen; 1996; 27(3):202-10. PubMed ID: 8625956
[TBL] [Abstract][Full Text] [Related]
15. A new transgenic mouse mutagenesis test system using Spi- and 6-thioguanine selections.
Nohmi T; Katoh M; Suzuki H; Matsui M; Yamada M; Watanabe M; Suzuki M; Horiya N; Ueda O; Shibuya T; Ikeda H; Sofuni T
Environ Mol Mutagen; 1996; 28(4):465-70. PubMed ID: 8991079
[TBL] [Abstract][Full Text] [Related]
16. Transmission of mutations in the lacI transgene to the offspring of ENU-treated Big Blue male mice.
Barnett LB; Tyl RW; Shane BS; Shelby MD; Lewis SE
Environ Mol Mutagen; 2002; 40(4):251-7. PubMed ID: 12489115
[TBL] [Abstract][Full Text] [Related]
17. The cII locus in the MutaMouse system.
Swiger RR; Cosentino L; Shima N; Bielas JH; Cruz-Munoz W; Heddle JA
Environ Mol Mutagen; 1999; 34(2-3):201-7. PubMed ID: 10529745
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of mutagenic mode of action in Big Blue mice fed methylphenidate for 24 weeks.
Manjanatha MG; Shelton SD; Dobrovolsky VN; Shaddock JG; McGarrity LG; Twaddle NW; Moore MM; Mattison DR; Slikker W; Morris SM
Mutat Res; 2009; 680(1-2):43-8. PubMed ID: 19778631
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the in vivo genotoxic potential of three carcinogenic aromatic amines using the Big Blue transgenic mouse mutation assay.
Suter W; Ahiabor R; Blanco B; Locher F; Mantovani F; Robinson M; Sreenan G; Staedtler F; Swingler T; Vignutelli A; Perentes E
Environ Mol Mutagen; 1996; 28(4):354-62. PubMed ID: 8991064
[TBL] [Abstract][Full Text] [Related]
20. Transgenic lambda medaka as a new model for germ cell mutagenesis.
Winn RN; Majeske AJ; Jagoe CH; Glenn TC; Smith MH; Norris MB
Environ Mol Mutagen; 2008 Apr; 49(3):173-84. PubMed ID: 18213652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
